Showing results (1071-1080 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|April 7, 2010
CIAPIN1 as a therapeutic target in cancerXiaohua Li, Kaichun Wu, Daiming FanExpert Opinion on Therapeutic Targets|March 19, 2015
Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathiesSimon Moussaud, Siobhan Malany, Alka Mehta, et al.Expert Opinion on Therapeutic Targets|February 6, 2023
H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeuticsJulian S Rechberger, Blake T Power, Erica A Power, et al.Expert Opinion on Therapeutic Targets|August 13, 2022
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancerMichela Cortesi, Michele Zanoni, Roberta Maltoni, et al.Expert Opinion on Therapeutic Targets|March 22, 2023
Treatment update for vitiligo based on autoimmune inhibition and melanocyte protectionBo Xie, Yuqi Zhu, Yuqing Shen, et al.Expert Opinion on Therapeutic Targets|March 22, 2023
Papain exerts an anti-atherosclerosis effect with suppressed MPA-mediated foam cell formation by regulating the MAPK and PI3K/Akt-NF-κB pathwaysXianming Fei, Lianlian Pan, Wufen Yuan, et al.Expert Opinion on Therapeutic Targets|March 21, 2023
Parasite and host kinases as targets for antimalarialsHan Wee Ong, Jack Adderley, Andrew B Tobin, et al.Expert Opinion on Therapeutic Targets|November 12, 2022
Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical dataMaria Lina Tornesello, Anna Lucia Tornesello, Noemy Starita, et al.Expert Opinion on Therapeutic Targets|August 20, 2025
Uncovering immune pathways for therapeutic targeting of hypertensionKatherine S Deck, Christoph J Mora, Shuoqiu Deng, et al.Expert Opinion on Therapeutic Targets|February 22, 2025
Targeting glypican 3 by immunotoxins: the promise of immunotherapy in hepatocellular carcinomaElham Rismani, Nikoo Hossein-Khannazer, Moustapha Hassan, et al.Pageof 232